Cadence Pharmaceuticals To Present At The Deutsche Bank Securities, Inc. 37th Annual Health Care Conference In Boston On May 8,

  //health-fitness.news-articles.net/content/2012/ .. l-health-care-conference-in-boston-on-may-8.html
  Published in Health and Fitness on Wednesday, May 2nd 2012 at 13:05 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

Cadence Pharmaceuticals To Present At The Deutsche Bank Securities, Inc. 37th Annual... -- SAN DIEGO, May 2, 2012 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about CADX

SAN DIEGO, May 2, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: [ CADX ]), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's Chief Commercial Officer Scott Byrd will present the company's corporate overview on Tuesday, May 8, 2012 at 4:50pm Eastern Time (1:50pm Pacific Time) during the Deutsche Bank Securities, Inc. 37th Annual Health Care Conference at the Intercontinental Boston Hotel in Boston.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at [ www.cadencepharm.com ] in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 30 days.

About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.  The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the "Investors" page of [ www.cadencepharm.com ], under "Events and Presentations." 

SOURCE Cadence Pharmaceuticals, Inc.

RELATED LINKS
[ http://www.cadencepharm.com ]